Bullboard - Stock Discussion Forum Viking Therapeutics Inc VKTX

Healthcare Biotechnology

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b... see more

Add To Watchlist

NDAQ:VKTX - Post Discussion

Viking Therapeutics Inc > Weight Loss Drug Market Gets Crowded As Viking Therapeutics

View:

Post by whytestocks on Feb 27, 2024 10:15am

Weight Loss Drug Market Gets Crowded As Viking Therapeutics

Just In: $VKTX Weight Loss Drug Market Gets Crowded As Viking Therapeutics Drops Encouraging Phase 2 Data From Obesity Study | BenzingaTuesday, Viking Therapeutics Inc (NASDAQ:VKTX) released top-line results from its Phase 2 trial of VK2735, a dual agonist of the glucagon...VKTX - Weight Loss Drug Market Gets Crowded As Viking Therapeutics Drops Encouraging Phase 2 Data From Obesity Study | Benzinga